Latham Steers Boston Scientific's $465M Spinal Device Deal
Boston Scientific said Thursday it has agreed to buy a private equity-backed medical device maker that focuses on spinal stenosis in a $465 million deal guided by Latham & Watkins, as...To view the full article, register now.
Already a subscriber? Click here to view full article